Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Danimer Scientific announces $15 million stock and warrants sale

Published 21/03/2024, 12:28 pm
Updated 21/03/2024, 12:28 pm
© Reuters.

BAINBRIDGE, Ga. - Danimer Scientific, Inc. (NYSE: DNMR), a company specializing in biodegradable materials, has announced a registered direct offering involving the sale of 15 million shares of common stock and accompanying warrants. The shares and stock equivalents are priced at $1.00 each, with warrants exercisable at $1.33 per share starting six months post-issuance and expiring after five and a half years. The transaction is anticipated to close around March 25, 2024, contingent on customary closing conditions.

Roth Capital Partners is serving as the exclusive placement agent for the offering. Danimer Scientific expects to raise approximately $15 million before deductions for placement agent fees and other related expenses. The net proceeds are intended for working capital and other general corporate purposes.

The securities are being offered pursuant to an effective shelf registration statement, and details regarding the offering will be available through a prospectus supplement filed with the Securities and Exchange Commission (SEC). Interested parties can obtain copies of these documents from Roth Capital Partners or the SEC's website.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.